Treatment of calcinosis cutis with sodium thiosulfate therapy - 10/10/20
Doi : 10.1016/j.jaad.2020.06.996
Rachel M. Howard, BS a, ⁎ 
, Gideon P. Smith, MD, PhD b
, Gideon P. Smith, MD, PhD b a University of Washington School of Medicine, Seattle, Washington
b Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
∗Correspondence to: Rachel Howard, BS, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195University of Washington School of Medicine1959 NE Pacific StSeattleWA98195
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the Institutional Review Board (MGH approval #2014P001508). |
|
| Reprints not available from the author(s). |
© 2020
Publié par Elsevier Masson SAS.
Vol 83 - N° 5
P. 1518-1520 - novembre 2020 Retour au numéro
Article précédent
- Dermatologic disorders in transgender patients: A retrospective cohort of 442 patients
- Reese L. Imhof, Caroline J. Davidge-Pitts, Rachel Y.N. Miest, Todd B. Nippoldt, Megha M. Tollefson
- Characterizing dupilumab facial redness in children and adolescents: A single-institution retrospective chart review
- Sonal Muzumdar, Micaella Zubkov, Reid Waldman, Madeline E. DeWane, Rong Wu, Jane M. Grant-Kels
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?